Global Beta-Lactam Drugs Market Growth (Status and Outlook) 2023-2029

February 2023 | 86 pages | ID: G75917D8A10AEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Beta-Lactam Drugs Industry Forecast” looks at past sales and reviews total world Beta-Lactam Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Beta-Lactam Drugs sales for 2023 through 2029. With Beta-Lactam Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Beta-Lactam Drugs industry.

This Insight Report provides a comprehensive analysis of the global Beta-Lactam Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Beta-Lactam Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Beta-Lactam Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Beta-Lactam Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Beta-Lactam Drugs.

The global Beta-Lactam Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Beta-Lactam Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Beta-Lactam Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Beta-Lactam Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Beta-Lactam Drugs players cover GlaxoSmithKline plc, Pfizer, Inc., AstraZeneca plc, Merck & Co., Inc., Eli Lilly and Company and Shionogi & Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Beta-Lactam Drugs market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Penicillin
• Cephalosporins
• Carbapenem
• Monobacteria

Segmentation by application

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• GlaxoSmithKline plc
• Pfizer, Inc.
• AstraZeneca plc
• Merck & Co., Inc.
• Eli Lilly and Company
• Shionogi & Co., Ltd.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Beta-Lactam Drugs Market Size 2018-2029
  2.1.2 Beta-Lactam Drugs Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Beta-Lactam Drugs Segment by Type
  2.2.1 Penicillin
  2.2.2 Cephalosporins
  2.2.3 Carbapenem
  2.2.4 Monobacteria
2.3 Beta-Lactam Drugs Market Size by Type
  2.3.1 Beta-Lactam Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Beta-Lactam Drugs Market Size Market Share by Type (2018-2023)
2.4 Beta-Lactam Drugs Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Online Pharmacies
2.5 Beta-Lactam Drugs Market Size by Application
  2.5.1 Beta-Lactam Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Beta-Lactam Drugs Market Size Market Share by Application (2018-2023)

3 BETA-LACTAM DRUGS MARKET SIZE BY PLAYER

3.1 Beta-Lactam Drugs Market Size Market Share by Players
  3.1.1 Global Beta-Lactam Drugs Revenue by Players (2018-2023)
  3.1.2 Global Beta-Lactam Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Beta-Lactam Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 BETA-LACTAM DRUGS BY REGIONS

4.1 Beta-Lactam Drugs Market Size by Regions (2018-2023)
4.2 Americas Beta-Lactam Drugs Market Size Growth (2018-2023)
4.3 APAC Beta-Lactam Drugs Market Size Growth (2018-2023)
4.4 Europe Beta-Lactam Drugs Market Size Growth (2018-2023)
4.5 Middle East & Africa Beta-Lactam Drugs Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Beta-Lactam Drugs Market Size by Country (2018-2023)
5.2 Americas Beta-Lactam Drugs Market Size by Type (2018-2023)
5.3 Americas Beta-Lactam Drugs Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Beta-Lactam Drugs Market Size by Region (2018-2023)
6.2 APAC Beta-Lactam Drugs Market Size by Type (2018-2023)
6.3 APAC Beta-Lactam Drugs Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Beta-Lactam Drugs by Country (2018-2023)
7.2 Europe Beta-Lactam Drugs Market Size by Type (2018-2023)
7.3 Europe Beta-Lactam Drugs Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Beta-Lactam Drugs by Region (2018-2023)
8.2 Middle East & Africa Beta-Lactam Drugs Market Size by Type (2018-2023)
8.3 Middle East & Africa Beta-Lactam Drugs Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL BETA-LACTAM DRUGS MARKET FORECAST

10.1 Global Beta-Lactam Drugs Forecast by Regions (2024-2029)
  10.1.1 Global Beta-Lactam Drugs Forecast by Regions (2024-2029)
  10.1.2 Americas Beta-Lactam Drugs Forecast
  10.1.3 APAC Beta-Lactam Drugs Forecast
  10.1.4 Europe Beta-Lactam Drugs Forecast
  10.1.5 Middle East & Africa Beta-Lactam Drugs Forecast
10.2 Americas Beta-Lactam Drugs Forecast by Country (2024-2029)
  10.2.1 United States Beta-Lactam Drugs Market Forecast
  10.2.2 Canada Beta-Lactam Drugs Market Forecast
  10.2.3 Mexico Beta-Lactam Drugs Market Forecast
  10.2.4 Brazil Beta-Lactam Drugs Market Forecast
10.3 APAC Beta-Lactam Drugs Forecast by Region (2024-2029)
  10.3.1 China Beta-Lactam Drugs Market Forecast
  10.3.2 Japan Beta-Lactam Drugs Market Forecast
  10.3.3 Korea Beta-Lactam Drugs Market Forecast
  10.3.4 Southeast Asia Beta-Lactam Drugs Market Forecast
  10.3.5 India Beta-Lactam Drugs Market Forecast
  10.3.6 Australia Beta-Lactam Drugs Market Forecast
10.4 Europe Beta-Lactam Drugs Forecast by Country (2024-2029)
  10.4.1 Germany Beta-Lactam Drugs Market Forecast
  10.4.2 France Beta-Lactam Drugs Market Forecast
  10.4.3 UK Beta-Lactam Drugs Market Forecast
  10.4.4 Italy Beta-Lactam Drugs Market Forecast
  10.4.5 Russia Beta-Lactam Drugs Market Forecast
10.5 Middle East & Africa Beta-Lactam Drugs Forecast by Region (2024-2029)
  10.5.1 Egypt Beta-Lactam Drugs Market Forecast
  10.5.2 South Africa Beta-Lactam Drugs Market Forecast
  10.5.3 Israel Beta-Lactam Drugs Market Forecast
  10.5.4 Turkey Beta-Lactam Drugs Market Forecast
  10.5.5 GCC Countries Beta-Lactam Drugs Market Forecast
10.6 Global Beta-Lactam Drugs Forecast by Type (2024-2029)
10.7 Global Beta-Lactam Drugs Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 GlaxoSmithKline plc
  11.1.1 GlaxoSmithKline plc Company Information
  11.1.2 GlaxoSmithKline plc Beta-Lactam Drugs Product Offered
  11.1.3 GlaxoSmithKline plc Beta-Lactam Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 GlaxoSmithKline plc Main Business Overview
  11.1.5 GlaxoSmithKline plc Latest Developments
11.2 Pfizer, Inc.
  11.2.1 Pfizer, Inc. Company Information
  11.2.2 Pfizer, Inc. Beta-Lactam Drugs Product Offered
  11.2.3 Pfizer, Inc. Beta-Lactam Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Pfizer, Inc. Main Business Overview
  11.2.5 Pfizer, Inc. Latest Developments
11.3 AstraZeneca plc
  11.3.1 AstraZeneca plc Company Information
  11.3.2 AstraZeneca plc Beta-Lactam Drugs Product Offered
  11.3.3 AstraZeneca plc Beta-Lactam Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 AstraZeneca plc Main Business Overview
  11.3.5 AstraZeneca plc Latest Developments
11.4 Merck & Co., Inc.
  11.4.1 Merck & Co., Inc. Company Information
  11.4.2 Merck & Co., Inc. Beta-Lactam Drugs Product Offered
  11.4.3 Merck & Co., Inc. Beta-Lactam Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Merck & Co., Inc. Main Business Overview
  11.4.5 Merck & Co., Inc. Latest Developments
11.5 Eli Lilly and Company
  11.5.1 Eli Lilly and Company Company Information
  11.5.2 Eli Lilly and Company Beta-Lactam Drugs Product Offered
  11.5.3 Eli Lilly and Company Beta-Lactam Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Eli Lilly and Company Main Business Overview
  11.5.5 Eli Lilly and Company Latest Developments
11.6 Shionogi & Co., Ltd.
  11.6.1 Shionogi & Co., Ltd. Company Information
  11.6.2 Shionogi & Co., Ltd. Beta-Lactam Drugs Product Offered
  11.6.3 Shionogi & Co., Ltd. Beta-Lactam Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Shionogi & Co., Ltd. Main Business Overview
  11.6.5 Shionogi & Co., Ltd. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Beta-Lactam Drugs Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Penicillin
Table 3. Major Players of Cephalosporins
Table 4. Major Players of Carbapenem
Table 5. Major Players of Monobacteria
Table 6. Beta-Lactam Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Beta-Lactam Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Beta-Lactam Drugs Market Size Market Share by Type (2018-2023)
Table 9. Beta-Lactam Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Beta-Lactam Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Beta-Lactam Drugs Market Size Market Share by Application (2018-2023)
Table 12. Global Beta-Lactam Drugs Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Beta-Lactam Drugs Revenue Market Share by Player (2018-2023)
Table 14. Beta-Lactam Drugs Key Players Head office and Products Offered
Table 15. Beta-Lactam Drugs Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Beta-Lactam Drugs Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Beta-Lactam Drugs Market Size Market Share by Regions (2018-2023)
Table 20. Global Beta-Lactam Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Beta-Lactam Drugs Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Beta-Lactam Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Beta-Lactam Drugs Market Size Market Share by Country (2018-2023)
Table 24. Americas Beta-Lactam Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Beta-Lactam Drugs Market Size Market Share by Type (2018-2023)
Table 26. Americas Beta-Lactam Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Beta-Lactam Drugs Market Size Market Share by Application (2018-2023)
Table 28. APAC Beta-Lactam Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Beta-Lactam Drugs Market Size Market Share by Region (2018-2023)
Table 30. APAC Beta-Lactam Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Beta-Lactam Drugs Market Size Market Share by Type (2018-2023)
Table 32. APAC Beta-Lactam Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Beta-Lactam Drugs Market Size Market Share by Application (2018-2023)
Table 34. Europe Beta-Lactam Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Beta-Lactam Drugs Market Size Market Share by Country (2018-2023)
Table 36. Europe Beta-Lactam Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Beta-Lactam Drugs Market Size Market Share by Type (2018-2023)
Table 38. Europe Beta-Lactam Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Beta-Lactam Drugs Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Beta-Lactam Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Beta-Lactam Drugs Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Beta-Lactam Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Beta-Lactam Drugs Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Beta-Lactam Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Beta-Lactam Drugs Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Beta-Lactam Drugs
Table 47. Key Market Challenges & Risks of Beta-Lactam Drugs
Table 48. Key Industry Trends of Beta-Lactam Drugs
Table 49. Global Beta-Lactam Drugs Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Beta-Lactam Drugs Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Beta-Lactam Drugs Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Beta-Lactam Drugs Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. GlaxoSmithKline plc Details, Company Type, Beta-Lactam Drugs Area Served and Its Competitors
Table 54. GlaxoSmithKline plc Beta-Lactam Drugs Product Offered
Table 55. GlaxoSmithKline plc Beta-Lactam Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. GlaxoSmithKline plc Main Business
Table 57. GlaxoSmithKline plc Latest Developments
Table 58. Pfizer, Inc. Details, Company Type, Beta-Lactam Drugs Area Served and Its Competitors
Table 59. Pfizer, Inc. Beta-Lactam Drugs Product Offered
Table 60. Pfizer, Inc. Main Business
Table 61. Pfizer, Inc. Beta-Lactam Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Pfizer, Inc. Latest Developments
Table 63. AstraZeneca plc Details, Company Type, Beta-Lactam Drugs Area Served and Its Competitors
Table 64. AstraZeneca plc Beta-Lactam Drugs Product Offered
Table 65. AstraZeneca plc Main Business
Table 66. AstraZeneca plc Beta-Lactam Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. AstraZeneca plc Latest Developments
Table 68. Merck & Co., Inc. Details, Company Type, Beta-Lactam Drugs Area Served and Its Competitors
Table 69. Merck & Co., Inc. Beta-Lactam Drugs Product Offered
Table 70. Merck & Co., Inc. Main Business
Table 71. Merck & Co., Inc. Beta-Lactam Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Merck & Co., Inc. Latest Developments
Table 73. Eli Lilly and Company Details, Company Type, Beta-Lactam Drugs Area Served and Its Competitors
Table 74. Eli Lilly and Company Beta-Lactam Drugs Product Offered
Table 75. Eli Lilly and Company Main Business
Table 76. Eli Lilly and Company Beta-Lactam Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Eli Lilly and Company Latest Developments
Table 78. Shionogi & Co., Ltd. Details, Company Type, Beta-Lactam Drugs Area Served and Its Competitors
Table 79. Shionogi & Co., Ltd. Beta-Lactam Drugs Product Offered
Table 80. Shionogi & Co., Ltd. Main Business
Table 81. Shionogi & Co., Ltd. Beta-Lactam Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Shionogi & Co., Ltd. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Beta-Lactam Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Beta-Lactam Drugs Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Beta-Lactam Drugs Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Beta-Lactam Drugs Sales Market Share by Country/Region (2022)
Figure 8. Beta-Lactam Drugs Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Beta-Lactam Drugs Market Size Market Share by Type in 2022
Figure 10. Beta-Lactam Drugs in Hospital Pharmacies
Figure 11. Global Beta-Lactam Drugs Market: Hospital Pharmacies (2018-2023) & ($ Millions)
Figure 12. Beta-Lactam Drugs in Retail Pharmacies
Figure 13. Global Beta-Lactam Drugs Market: Retail Pharmacies (2018-2023) & ($ Millions)
Figure 14. Beta-Lactam Drugs in Online Pharmacies
Figure 15. Global Beta-Lactam Drugs Market: Online Pharmacies (2018-2023) & ($ Millions)
Figure 16. Global Beta-Lactam Drugs Market Size Market Share by Application in 2022
Figure 17. Global Beta-Lactam Drugs Revenue Market Share by Player in 2022
Figure 18. Global Beta-Lactam Drugs Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Beta-Lactam Drugs Market Size 2018-2023 ($ Millions)
Figure 20. APAC Beta-Lactam Drugs Market Size 2018-2023 ($ Millions)
Figure 21. Europe Beta-Lactam Drugs Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Beta-Lactam Drugs Market Size 2018-2023 ($ Millions)
Figure 23. Americas Beta-Lactam Drugs Value Market Share by Country in 2022
Figure 24. United States Beta-Lactam Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Beta-Lactam Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Beta-Lactam Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Beta-Lactam Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Beta-Lactam Drugs Market Size Market Share by Region in 2022
Figure 29. APAC Beta-Lactam Drugs Market Size Market Share by Type in 2022
Figure 30. APAC Beta-Lactam Drugs Market Size Market Share by Application in 2022
Figure 31. China Beta-Lactam Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Beta-Lactam Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Beta-Lactam Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Beta-Lactam Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Beta-Lactam Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Beta-Lactam Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Beta-Lactam Drugs Market Size Market Share by Country in 2022
Figure 38. Europe Beta-Lactam Drugs Market Size Market Share by Type (2018-2023)
Figure 39. Europe Beta-Lactam Drugs Market Size Market Share by Application (2018-2023)
Figure 40. Germany Beta-Lactam Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Beta-Lactam Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Beta-Lactam Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Beta-Lactam Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Beta-Lactam Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Beta-Lactam Drugs Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Beta-Lactam Drugs Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Beta-Lactam Drugs Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Beta-Lactam Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Beta-Lactam Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Beta-Lactam Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Beta-Lactam Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Beta-Lactam Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 54. APAC Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 55. Europe Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 57. United States Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 58. Canada Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 61. China Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 62. Japan Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 63. Korea Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 65. India Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 66. Australia Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 67. Germany Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 68. France Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 69. UK Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 70. Italy Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 71. Russia Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 72. Spain Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 75. Israel Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Beta-Lactam Drugs Market Size 2024-2029 ($ Millions)
Figure 78. Global Beta-Lactam Drugs Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Beta-Lactam Drugs Market Size Market Share Forecast by Application (2024-2029)